Compare LWAY & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LWAY | CYRX |
|---|---|---|
| Founded | 1986 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.4M | 419.3M |
| IPO Year | 1995 | 2008 |
| Metric | LWAY | CYRX |
|---|---|---|
| Price | $29.39 | $16.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $34.50 | $13.31 |
| AVG Volume (30 Days) | 142.1K | ★ 849.0K |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 48.33 | ★ 156.22 |
| EPS | ★ 0.30 | N/A |
| Revenue | $103,350,000.00 | ★ $176,177,000.00 |
| Revenue This Year | $16.64 | $11.06 |
| Revenue Next Year | $17.28 | $8.45 |
| P/E Ratio | $101.10 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.31 | $6.69 |
| 52 Week High | $34.20 | $16.73 |
| Indicator | LWAY | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.88 | 61.58 |
| Support Level | $22.03 | $9.28 |
| Resistance Level | $34.20 | $16.73 |
| Average True Range (ATR) | 1.35 | 0.65 |
| MACD | 0.66 | -0.07 |
| Stochastic Oscillator | 75.88 | 71.39 |
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.